~ ~
i I I
R£FERf~CES
~ferences
8 REFERENCES
1. Abe F, Tateyma M, Shibuya H, Azumi Nand Ommura Y (1985) Experimental
candidiasis in iron overload. Mycopathologia 89: 59-63.
2. Aeed P A, Young CL, Nagiec MM, and. Elhammer Ap (2009) Inhibition of Inositol
Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A. Antimicrob Agents
Chemother 53(2): 496-504.
3. Albertson GD, Niimi M, Cannon RD & Jenkinson H F (1996) Multiple efflux
mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents
Chemother 40: 2835-2841.
4. Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE, Filler SG and Hube
B (2008) The hyphal-associated adhesion and invasin Als3 of Candida albicans mediates
iron acquisition from host ferritin. PLoS Pathog 4: e1000217. - .
5. Almeida RS, Wilson D and Hube B (2009) Candida albicans iron acquisition within the
host FEMS Yeast Res 9 1000-1012.
6. Ansari S, Gupta P, Mahanty SK and Prasad R (1993) The Uptake of Amino Acids by erg
Mutants of Candida albicans. J Med Vet Mycol31: 377-386.
7. Arosio P, Adelman TG an Drysdale JW (1978) On ferritin heterogeneity. Further
evidence for heteropolymers. J Bioi Chem 253: 4451--4458.
8. Arosio P, Yokota M and Drysdale JW (1976) Structural and immunological relationships
of isoferritins in normal and malignant cells. Cancer Res 36: 1735-1739.
9. Arthington-Skaggs BA, Jradi H, Desai T & Morrison CJ (1999) Quantitation of
ergosterol content: novel method for determination of fluconazole susceptibility of
Candida albicans. J Clin Microbiol37: 3332-3337.
184
1?§ferences
1 O. Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, Kaplan J.
(1994) the FET3 gene of S cerevisiae encodes a multicopperoxidase required for ferrous
iron uptake. Cell 76: 403-410.
11. Bader T, Bodendorfer B, Schroppel K, and Morschhauser J (2007) Calcineurin I~
Essential for Virulence in Candida albicans Infection and Immunity 71(9): 5344-5354.
12. Baek YU, Li M and Davis DA (2008) Candida albicans ferric reductases an;
differentially regulated in response to distinct forms of iron limitation by the Rim 1 0 1 ane
CBF transcription factors. Eukaryot Cell 7: 1168-1179.
13. BailIe GS & Douglas LJ (1999) Role of dimorphism in the development of Candide.
albicans biofilms. J Med Micobiol48: 671-679.
14. Bali PK & Aisen P (1992) Receptor-induced switch in site-site cooperativity during iror
release by transferrin. Biochemistry 31: 3963-3967.
15. Banerjee D, Lelandais G, Shukla S, Mukhopadhyay G, Jacq C, Frederic Devaux Fane
Prasad R (2008) Responses of Pathogenic and Nonpathogenic Yeast Species to Steroid~
Reveal the Functioning and Evolution of Multidrug Resistance Transcriptional Networks
Eukaryot Cell 7 (1): 68-77.
16. Banerjee D, Pillai B, Karnani N, Mukhopadhyay G and Prasad R (2004) Genome-wide
expression profile of steroid response in Saccharomyces cerevisiae. Biochem Biophys Res
Commun. 317: 406-413.
17. Banin E, Vasil ML and Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm
formation. PNAS 102: 11076-11081.
18. Banuett F (1998) Signalling in the yeast; an informational cascade with links to the
filamentous fungi. Mol. Bioi. Rev. 62; 249-274.
185
1?§ferences
19. Barluzzi R, Saleppico S, Nocentini A, Boelaert JR, Neglia R, Bistoni F and Blasi E
(2002) Iron overload exacerbates experimental meningoencephalitis by Cryptococcus
neoformans. J Neuroimmunol132: 140-146.
20. Barnes K, Dickstein B, Cutler GB, Fojo T and Bates SE (1996) Steroid accumulation,
and antagonism of P-glycoprtein in multi drug resistant cells. Biochemistry 35: 4820-
4827.
21. Bastidas RJ, Reedy JL, Johansson HM, Heitman J and Maria E. Cardenas ME (2008)
Signaling cascades as drug targets in model and pathogenic fungi Curr Opin lnvestig
Drugs. 9(8): 856-864.
22. Batova M, Borecka-Melkusova S, Simockova M, Dzugasova V, Gova E and Subik J
(2008) Functional characterization of the CgPGSl gene reveals a link between
mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata Curr
Genet 53:313-322
23. Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM and Koltin Y (1994) Candida
albicans gene encoding resistance to benomyl and methotrexate is a multi drug resistance
gene. Antimicrob Agents Chemother 38: 648-652.
24. Blankenship JR, Wormley, FL, Boyce MK, Schell WA, Filler SG, Perfect JR., and
Heitman J (2003) Calcineurin Is Essential for Candida albicans Survival in Serum and
Virulence Eukaryotic Cell 2(3): 422--430.
25. Bligh EG, and. Dyer WJ (1959). A rapid method of total lipid extraction and
purification. Can. J Biochem. Physiol. 37:911-917.
26. Bockmuhl DP, Krishnamurthy S, Gerads M, Sonneborn A and Ernst JF (2001) Distinct
and redundant roles of the two protein kinase A isoforms Tpkl p and Tpk2p in
morphogenesis and growth of Candida albicans. Mol Microbiol42: 1243-1257.
186
1?§ferences
27. Braun BR and Johnson AD (2000) TUP1, CPHl and EFGl make independent
contributions to filamentation in Candida albicans. Genetics 155: 57-67.
28. Breuer W, Epsztejn Sand Cabantchik ZI (1995) Iron acquired from transferring by K562
cells is delivered into a cytoplasmic pool of chelatable Iron (II). J Bioi Chern 270: 24209-
24215.
29. Brown AJ and Gow NA (1999) Regulatory networks controlling Candida albicans
morphogenesis. Trends Microbiol 7: 333-338.
30. Brown AJP and Gow NA (1999) Regulatory networks controlling Candida albicans
morphogenesis. Trends Microbiol7: 333-338.
31. Brown AJP (2002) Morphogenetic signaling pathways. In the book Candida and
Candidiasis. (Washington, D.C.:ASM press) pp:95-106.
32. Brown AJP and Gow NA (1999) Regulatory Netwoks Controlling Candida albicans
Morphogenesis. Trends Microbiol7: 333-338.
33. Brown DH, Guisani AD, Chen X and Kumamoto CA (1999) Filamentous Growth of
Candida albicans in Response to Physical Environmental Cues and Its Regulation by the
Unique CZFl Gene. Mol Microbiol18I: 7070-7079.
34. Bullen JJ, Rogers HJ, Spalding PB and Ward CG (2006) Natural resistance, iron and
infection: challenge for clinical medicine. J Med Microbiol55: 251-258.
35. Buss JL, Greene BT, Turner J, Torti FM and Torti SV (2004) Iron chelators in cancer
chemotherapy. Curro Top.Med. Chern. 4: 1623-1635.
36. Cabantchik ZI, Glickstein H, Milgram P and Breuer W (1996) A fluorescence assay for
assessing chelation of intracellular iron in a membrane model system and in mammalian
cells. Anal Biochern 233: 221-227.
187
~ferences
37. Calderone RA (2002) Candida and Candidiasis. Washington DC: American Society for
Microbiology Press.
38. Calera JA, Zhao XJ and Calderone R (2000) Defective hypha 1 development and
avirulence caused by a deletion of the SSKI response regulator gene in Candida albicans.
Infection and Immunity. 68: 518-525.
39. Catrin Stichtemoth and Joachim F. Ernst (2009) Hypoxic Adaptation by Efgl Regulates
Biofilm Formation by Candida albicans App Env Microbiol75 (11): 3663-3672
40. Cerbon J, Falcon A, Hem' Andez-Luna C and Segura-Cobos D (2005) Inositol
phosphoceramide synthase is a regulator of intracellular levels of diacylglycerol and
cerami de during the G 1 to S transition in Saccharomyces cerevisiae Biochem. 1. 388,
169-176.
41. Chandra J, Kuhn DM, Mukherjee PK Hoyer LL, McCormick T and Ghannoum MA
(2001a) Biofilm formation by the fungal pathogen Candida albicans-development,
architecture and drug resistance. J Bacteriol183: 5385-5394.
42. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Douglas LJ and Ghannoum MA
(2001b) Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro. J
Dent Res 80: 903-908.
43. Chau AS, Gumani M, Hawkinson R, Laverdiere M, Cacciapuoti A and McNicholas PM
(2005) Inactivation of Sterol ~5,6-Desaturase Attenuates Virulence in Candida albicans
Antimicrob Agents Chemother 49: 3646-3651.
44. Chen CG, Yang YL, Shih HI, Su CL and Lo HJ (2004) CaNdt80 is involved in drug
resistance in Candida albicans by regulating CDRI. Antimicrob Agents Ch 48: 4505-
4512.
188
1?§ferences
45. Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC and Lo HJ (2009) Replp
negatively regulating MDRI efflux pump involved in drug resistance in Candida
albicans. Fungal Genet BioI 46: 714-720.
46. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC and Colgan SP
(2002) Hypoxia-inducible factor-I-dependent regulation of the multi drug resistance
(MDRl) gene. Cancer Res. 62: 3387-3394.
47. Comerford KM and Colgan SP (2004a) Assessing oxygen sensitivity of the multidrug
resistance (MDR) gene. Methods Enzymol. 381: 376-387.
48. Comerford KM,Cummins EP and Taylor CT (2004b) c-Jun NH2-terminal kinase
activation contributes to hypoxia-inducible factor! a-dependent P-glycoprotein expression
in hypoxia. Cancer Res. 64: 9057-9061.
49. Coste AT, Turner V, Ischer F, Morschhauser J, Forche A, Selmecki A, Berman J, Bille J,
Sanglard D (2006) A mutation in Tac 1 p, a transcription factor regulating CDRI and
CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal
resistance in Candida albicans. Genetics 172: 2139-2156.
50. Coste AT, Karababa M, Ischer F, Bille J and Sanglard D (2004) TAC1, transcriptional
activator of CDR genes, is a new transcription factor involved in the regulation of
Candida albicans ABC transporters CDRI and CDR2. Eukaryot Cell 3: 1639-1652.
51. Coste AT, Kararaba M, Ischer F, Bille J and Sanglard D. (2004) TAC], transcriptional
activator of CDR] genes, is a new transcription factor involved in the regulation of
Candida albicans ABC transporters CDR] and CDR2. Eukaryot Cell 3: 1639-1652.
52. Cowen LE (2009) Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug
Resistance PLoS Pathogens 5(7): el000532.
53. Cowena LE and Lindquist S (2005) Hsp90 potentiates the rapid evolution of new traits:
drug resistance in diverse fungi. Science 309 (5744): 2185-2189.
189
~ferences
54. Cowen LE, Singha SD, Ko·· hlerb JR, Collinsa C, Zaasc AK, Schellc W A, Azizc H,
Mylonakisd E, Perfectc,e JR, Whitesellf L and Susan L (2009) Harnessing Hsp90
function as a powerful, broadly effective therapeutic strategy for fungal infectious disease
Proc. Natl. Acad. Sci 106 (8): 2818-2823.
55. Craven RJ, Mallory JC, and Hand RA (2007) Regulation of Iron Homeostasis Mediated
by the Heme-binding Protein Dap 1 (Damage Resistance Protein 1) via the P450 Protein
ErglllCyp51 J BioI. Chem 282(50): 36543-36551
56. Cruz MC, Goldstein AL, Blankenship JR, Poeta MD, Davis D, Cardenas ME, Perfect JR,
McCusker JH and Heitman J (2002) Calcineurin is essential for survival during
membrane stress in Candida albicans. EMBO J 21(4): 546-559.
57. Csank C, Makris C, Meloche S, Schroppel K, Rollinghoff M, Dignard D, Thomas DY
and Whiteway M (1997) Derepressed hyphal growth and reduced virulence in a VH 1
family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol
Bioi Cell 8(12): 2539-51.
58. Das M, and Datta A (1985) Steroid binding protein(s) in yeasts. Biochem. Int. 11: 171-
176.
59. Daum G, Lees N.D, Bard M and Dickson R (1998) Biochemistry, cell biology and
molecular biology oflipids of Saccharomyces cerevisiae. Yeast 14:1471-510.
60. Davis D (2003) Adaptation to environmental pH in Candida albicans and its relation to
pathogenesis. Curr Genet 44: 1-7
61. Davis D (2009) How human pathogenic fungi sense and adapt to pH: the link to virulence
Current Opinion in Microbiology. 12: 365-370.
62. de Micheli M, Bille J, Schueller C and Sanglard D. (2002) A common drug responsive
element mediates the upregulation of the Candida albicans ABC transporters CDR1 and
CDR2, two genes involved in antifungal drug resistance. Mol Microbiol43: 1197-1214.
190
~ferences
63. Del Sorbo G, Schoonbeek HJ and De Waard MA (2000) Fungal Transporters Involved in
Efflux of Natural Toxic Compounds and Fungicides. Fung Genet and Bioi 30: 1-15.
64. Devaiah, SP, Roth MR, Baughman E, Li M, Tamura P, Jeannotte R, Welti R and. Wang
X (2006). Quantitative profiling of polar glycerolipid species from organs of wild-type
Arabidopsis and a phospholipase Dalphal knockout mutant. Phytochemistry 67: 1907-
1924.
65. Doedt T, Krishnamurthy S, Bockmuhl DP, Tebarth B, Stenpel C, Russell CL, Brown AJP
and Ernst JF (2004) APSES proteins regulate morphogenesis and metabolism in Candida
albicans. Mol Bioi Cell 15: 3167-3180.
66. Doherty CP (2007) Host-pathogen interactions: the role ofiron.1 Nutr 137: 1341-1344.
67. Dunkel N, Blass J, Rogers PD and Morschhauser J (2008a) Mutations in the multi drug
resistance regulator MRRl, followed by loss of heterozygosity, are the main cause of
MDRI overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol
69: 827-840.
68. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhauser J and Rogers PD (2008b) A
gain-of-function mutation in the transcription factor Upc2p causes upregulation of
ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida
albicans isolate. Eukaryot Cell 7: 1180-1190.
69. Eck R, Hundt S, Hartl A, Roemer E and Kunkel W (1999) A multi copper oxidase gene
from Candida albicans: cloning, characterization and disruption. Microbiology. 145:
2415-2422.
70. Ejsinga CS, Sampaioa JL, Surendranatha V, Duchoslavb E, Ekroosc K, Klemma RW,
Simonsa K, and Shevchenkoa A, (2009) Global analysis of the yeast lipidome by
quantitative shotgun mass spectrometry. Proc Natl Acad Sci 106 (7): 2136-2141
71. Emery T (1980) Iron deprivation as biological defense mechanism. Nature 287: 776-777.
191
r.R.gferences
72. Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C and Cabantchik ZI
(1999) H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress
response and induces multi drug resistance properties Blood 94: 3593-3603.
73. Ernst JF & Schmidt A (2000) Dimorphism in Human Pathogenic and Apathogenic
Yeasts. Karger, Switzerland.
74. Ernst JF (2000) Transcription factors III Candida albicans- environmental control of
morphogenesis. Microbiology 146: 1763-1774.
75. Espinell-Ingroff A, Barchiesi F, Hazen KC, Martinez-Suarez JV and Scalise G (1998)
Standardization of Antifungal Susceptibility Testing and Clinical Relevance. Med Mycol
1: 58-78
76. Evans DM, Frazer IH & Martin NG (1999) Genetic and environmental causes of
variation in basal levels of blood cells. Twin Res 2: 250-257.
77. Fang D, Bao Y, Li X, Liu F, Cai K, Gao J and Liao Q (2010) Effects ofIron Deprivation
on Multidrug Resistance of Leukemic K562 Cells Chemotherapy 56: 9-16.
78. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser
C, Bader 0 and Sanglard D.et al. (2009) Gain of function mutations in CgPDRl of
Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS
Pathog 5 (1): e1000268.
79. Ferreira C, Bucchini D, Martin ME, Levi S, Arosio P, Grandchamp B and Beaumont C
(2000) Early embryonic lethality of H ferritin gene deletion in mice. J Bioi Chem 275:
3021-3024.
80. Fischbach MA, Lin H, Liu DR & Walsh CT (2006) How pathogenic bacteria evade
mammalian sabotage in the battle for iron. Nat Chem Bioi 2: 132-138.
81. Fletcher J & Huehns ER (1968) Function of transferrin. Nature 218: 1211-1214.
192
~ferences
82. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y (1991) Analysis of a
Candida albicans gene that encodes a novel mechanism for resistance to benomyl and
methotrexate. Mol Gen Genet 227:318-329.
83. Fonzi WA & Irwin MY (1993) Isogenic strain construction and gene mappmg m
Candida albicans. Genetics 134: 717-728.
84. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M & Morschhauser J (1998) Multiple
molecular mechanisms contribute to a stepwise development of fluconazole resistance in
clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.
85. Franz R, Ruhnke M & Morschhauser J (1999) Molecular aspects of fluconazole
resistance development in Candida albicans. Mycoses 42: 453-458.
86. Fratti RA, Belanger PH, Ghannoum MA, Edwards JE Jr & Filler SG (1998) Endothelial
cell injury caused by Candida albicans is dependent on iron. Infect Immun 66: 191-196.
87. Frasco MB and Barrett JF (1998) Importance of Antifungal Drug-Resistance: Clinical
Significance and Need for Novel Therapy. Exp Opin Invest Drugs 7: 175-198.
88. Furuyama K, Kaneko K & Vargas PD (2007) Heme as a magnificent molecule with
multiple missions: heme determines its own fate and governs cellular homeostasis.
Tohoku J Exp Med213: 1-16.
89. Gaur NA, Puri N, Karnani N, Mukhopadhyay G, Goswami SK and Prasad R (2004)
Identification of a negative regulatory element which regulates basal transcription of a
multidrug resistance gene CDRI of Candida albicans. FEMS Yeast Res 4: 389-399.
90. Ghannoum M and Rice LB (1999) Antifungal Agents: Mode of Action, Mechanism of
Resistance and Correlation of These Mechanisms With Bacterial Resistance. Clin
Microbial Rev 12: 501-512.
193
~ferences
91. Gil ML, Casanova M & Martinez 1P (1994) Changes in the cell wall glycoprotein
composition of Candida albicans associated to the inhibition of the germ tube formation
by EDTA. Arch Microbiol161: 489-494.
92. Guan XL, Souza CM, Pichler H, Dewhurst G, Schaad 0, Kajiwara K, Wakabayashi H,
Ivanova T, Castillon GA, Piccolis M, Abe F, Loewith R, Funato K, Wenk MR, and
Riezman H (2009) Functional Interactions between Sphingolipids and Sterols III
Biological Membranes Regulating Cell Physiology Mol Bioi Cell. 20:2083-2095.
93. Gujjar PR, Finucane M and Larsen B (1997) The effect of estradiol on Candida albicans
growth. Ann. Clin. Lab. Sci. 27: 151-156.
94. Gupta V, Kohli AK, Krishnamurthy S, Puri N, Aalamgeer SA, Panwar SL and Prasad R
(1998). Identification of mutant alleles of CaMDRJ, a major facilitator of Candida
albicans which confers multi drug resistance and its in vitro transcriptional activation.
Curr Genet 34: 192-199.
95. Halliwell Band Gutteridge 1M (1984) Free radicals, lipid peroxidation and cell damage.
Lancet 2 (8411): 1095
96. Hameed S, Prasad T, Banerjee D, Chandra A, Mukhopadhyay CK, Goswami SK, Lattif
AA, Chandra J, Mukherjee PK, Ghannoum MA and Prasad R (2008) Iron deprivation
induces EFG J -mediated hypha 1 development in Candida albicans without affecting
biofilm formation. FEMS Yeast Res. 8:744-755.
97. Han Y (2005) Utilization of ferroproteins by Candida albicans during candidastasis by
apotransferrin. Arch Pharm Res 28: 963-969.
98. Heymann P, Gerads M, Schaller M, Dromer F, Winkelmann G and Ernst JF (2002) The
siderophore iron transporter of Candida albicans (Sitlp/Arnlp) mediates uptake of
ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun 70:
5246-5255.
194
1?gferences
99. Howard DH (1999) Acquisition, transport and storage of iron by pathogenic fungi. Clin
Mirobiol Rev 12: 394-404.
100.Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ and Espenshade PJ.
(2007) DapllPGRMCI binds and regulates cytochrome P450 enzymes. Cell Metab.
5(2): 143-9.
101. Hwang CS, Rhie G, Kim ST, Kim YR, Huh WK, Baek YU and Kang SO (1999) Copper
and zinc-containing superoxide dismutase and its gene from Candida albicans. Biochim.
Biophys. Acta 1427:245-255.
102.Im YJ, Idkowiak-Baldys J, Thevissen K, Cammue BP and Takemoto lY.(2003) IPTl
independent sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant
defensin DmAMPl. FEMS Microbiol Lett. 223(2): 199-203.
103.Jain P, Akula I, and Edlind T (2003) Cyclic AMP Signaling Pathway Modulates
Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles
and Other Sterol Biosynthesis Inhibitors. Antimicrob Agents Chemother 47 (10): 3195-
3201
104. Kadosh D and Johnson AD (2001) Rfgl, a protein related to the Saccharomyces
cerevisiae hypoxic regulator Roxl, controls filamentous growth and virulence in Candida
albicans. Mol. Cell. Bioi. 21: 2496-2505.
105. Kakeya H, Miyazaki T, Miyazaki Y and Kohno S (2003) Azole resistance in Candida
spp. Nippon lshinkin Gakkai Zasshi. 44(2):87-92.
106. Kan VL, Geber A and Bennett, JE (1996) Enhanced oxidative killing of azole-resistant
Candida glabrata strains with ERG]] deletion. Antimicrob Agents Chemother 40: 1717-
1719.
195
r.R.gferences
107. Kamani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G
and Prasad R (2004). SREl and SRE2 are two specific steroid-responsive modules of
Candida drug resistance gene 1 (CDRl) promoter. Yeast 3: 219-239.
108. Kathleen MY, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodriguez-Zas SL, Kwast
KE, Ghannoum MA and Hoyer LL (2007) Temporal analysis of Candida albicans gene
expression during biofilm development. Microbiology 153: 2373-2385.
109. Kaur Rand Bachhawat AK (1999) The Yeast Multidrug Resistance Pump, Pdr5p,
Confers Reduced Drug Resistance in Erg Mutants of Saccharomyces cerevisiae.
Microbiology 145: 809-818.
Ito. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, Schumacher U and
Einsele H (1997) Resistance to Fluconazole and Cross-Resistance to Amphotericin B in
Candida albicans From AIDS Patients Caused by Defective Sterol A5,6_ Desaturation.
FEBS Lett 400: 80-82.
III. Kerridge D (1985) The protoplast membrane and antifungal drugs. Fungal protoplasts:
applications in biochemistry and genetics. Marcel Deker, New York, 135-169.
112. Kerridge D (1986) Mode of action of clinically important antifungal drugs. Adv
Microbial Physiol27: 1-72.
113. Knight SA, Vilaire G, Lesuisse E and Dancis A (2005) Iron acquisition from transferrin
by Candida albicans depends on the reductive pathway. Infect Immun 73: 5482-5492.
114. Knight SAB and Dancis A (2006) Reduction of 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) is dependent on CaFRE 1 0
ferric reductase for Candida albicans grown in unbuffered media. Microbiology 152:
2301-2308.
196
CR.§ferences
1 1 5. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A and Watanabe N
(2002) Endogenous reactive oxygen species is an important mediator of miconazole
antifungal effect. Antimicrob Agents Chemother 46: 3113-17.
116. Kohler JR and Fink GR (1996) Candida albicans strains heterozygous and homozygous
for mutations in mitogen-activated protein kinase signaling components have defects in
hyphal development. Proc Natl A cad Sci. 93: 13223-8.
117. Kohli AK, Srnriti M, Mukhopadhyay K and Prasad R (2002) In vitro low-level resistance
to azoles in Candida albicans is associated with changes in membrane lipid fluidity and
asymmetry. Antimicrob Agents Chemother 46: 1046-1052.
l18.Kontoghiorghes GJ and Weinberg ED (1995) Iron: Mammalian defense systems,
mechanisms of disease and chelation therapy approaches. Blood Rev 9: 33-45.
119.Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT and
Han X (2007) Increased bone marrow iron stores is an independent risk factor for
invasive aspergillosis in patients with high-risk hematologic malignancies and recipients
of allogeneic hematopoietic stem cell transplantation. Cancer 110: 1303-1306.
120. Kornitzer D (2009) Fungal mechanisms for host iron acquisition. Curr Opin Microb 12:
377-383.
121. Koshkin V and Greenberg ML (2002) Cardiolipin prevents rate-dependent uncoupling
and provides osmotic stability in yeast mitochondria. Biochem.J. 364, 317-322
122.Krishnamurthy S, Plaine A, Albert J, Prasad T, Prasad R and Ernst JF (2004) Dosage
dependent functions of fatty acid desaturase Ole 1 p in growth and morphogenesis of
Candida albicans. Microbiology 150: 1991-2003.
123. Kuhn DM, Balkis MM, Chandra J, Mukherjee PK and Ghannoum MA (2002) Uses and
limitations of the XTT assay in studies of Candida growth and metabolism. J Clin
Microbiol41: 506-508.
197
1?§ferences
124. Kuipers ME, Beljaars L, Van BN, Vries HG, Heegsma J, Van Den Berg 11, Meijer DK
and Swart PJ (2002) Conditions influencing the in vitro antifungal activity of lactoferrin
combined with antimycotics against clinical isolates of Candida. Impact on the
development of buccal preparations oflactoferrin. APMlS. 110: 290-298.
125. Kuipers ME, De Vries HG, Eikelboom MC, Meijer DK and Swart PJ (1999) Synergistic
fungistatic effects of lactoferrin in combination with antifungal drugs against clinical
Candida isolates. Antimicrob.Agents Chemother 43: 2635-2641.
126. Kuipers ME, Heegsma J, Bakker HI, Meijer DK, Swart PJ, Frijlink EW, Eissens AC, de
Vries-Hospers HG, and Van Den Berg 11 (2002) Design and fungicidal activity of
mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug
Deliv. 9:31-38.
127. Kumamoto CA and Vinces MD (2005) Contributions of hyphae and hyphae-co-regulated
genes to Candida albicans virulence. Cell Microbiol7: 1546-1554.
128.Labialle S, Gayet L, Marthinet E, Rigal D and Baggetto LG (2003) Transcriptional
regulators of the human multi drug resistance 1 gene: recent reviews. Biochem.
Pharmacol. 64: 943-948.
129. Lamb DC, Kelly DE, Schunck W-H, Shyadehi AZ, Akhtar M, Lowe DJ, Baldwin BC &
Kelly SL (1997) The mutation T315A in Candida albicans sterol 14a-demethylase causes
reduced enzyme activity and fluconazole resistance through reduced affinity. J Bioi Chem
272: 5682-5688.
130.Lan CY, Rodarte G, Murillo LA, Jones T, Davis RW, Dungan J, Newport G, & Agabian
N 2004 (2004) Regulatory networks affected by iron availability in Candida albicans.
Mol Microbiol 53: 1451-1469.
131. Lesuisse E, Knight SA, Camadro JM and Dancis A (2002) Siderophore uptake by
Candida albicans: effect of serum treatment and comparison with Saccharomyces
cerevisiae. Yeast 19: 329-340. 198
CJ?gferences
132.Levi S, Yewdall SJ, Harrison PM, Santambrogio P, Cozzi A, Rovida E, Albertini A and
Arosio P (1992) Evidence of H- and Lchains have co-operative roles in the iron-uptake
mechanism of human ferritin. Biochem J 288: 591-596.
133.Li L and Kaplan J (1996) Characterization of Yeast Methyl Sterol Oxidase (ERG25) and
identification ofa Human Homologue. J Bioi Chern 271(28):16927-15933.
134.Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A and Fink GR (1997)
Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
135.Lo HJ, Wang JS, Lin CY, Chen CG, Hsiao TY, Hsu CT, Su CL, Fann MJ, Ching YT and
Yang YL (2005) EFGl involved in drug resistance by regulating the expression of ERG3
in Candida albicans. Antimicrob Agents Chemother 49: 1413-15.
136.Low CP, Liew LP, Pervaiz S and Yang H (2005) Apoptosis and lipoapoptosis in the
fission yeast Schizosaccharomyces pombe. FEMS Yeast Res 5: 1199-1206.
137.Madani ND, Malloy PJ, Rodriguez-Pombo P, Krishnan AV and Feldman D. (1994)
Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is
inhibited by estradiol. Proc. Natl. Acad. Sci. 91: 922-926.
138.Maesaki S, Marichal P, Bossche HV, Sanglard D and Kohno S (1999) Rhodamine 6G
Efflux for the Detection of CDRI-Overexpressing Azole-Resistant Candida albicans
Strains. J Antimicrob Chemother 44: 27-31.
139. Mallory JC, Crudden G, Johnson BL, Caiqing MC, Charles A. Pierson CA, Bard M, and
Craven RJ. (2005) Dap1p, a Heme-Binding Protein That Regulates the Cytochrome P450
Protein Ergl1p/Cyp51p in Saccharomyces cerevisiae Mol. Cell. Bioi 25(5):1669-1679.
140.Malloy PJ, Zhao X, Madani ND and Feldman D (1993) Cloning and expression of the
gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein.
Proc. Natl. Acad. Sci. 90: 1902-1906.
199
~ferences
141. Manoharlal R, Gaur NA, Panwar SL, Morschhausef· J and Prasad R (2008)
Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression
of CDR] in Azole-Resistant Candida albicans. Antimicrob Agents Chemother 52 (4):
1481-1492
142.Manoharlal R, Gorantala J, Shamrma M, Sanglard D and Prasad R (2010) PAPI (poly
(A) polymerase) homozygosity and hyperadenylation are major determinants of increased
mRNA stability of CDRI in azole resistant clinical isolates of Candida albicans.
Microbiol156: 313-336
143. Marengo-Rowe AJ (2006) Structure-function relations of human hemoglobins.
Proceedings (Bayl Univ Med Cent) 19: 239-245.
144. Marichal P (1999) Mechanisms of Resistance to Azole Antifungal Compounds. Current
Opinion in Anti-infective Investigational Drugs 1: 318-333.
145. Marichal P, Bossche VR, Odds FC, Nobels G, Warnock DW, Timmerman V,
Broeckhoven VC, Fay S. and Mose-Larsen P (1997) Molecular Biological
Characterization of an Azole-Resistant Candida glabrata Isolate. Antimicrob Agents
Chemother 41: 2229-2237.
146.Martins MD and Rex JR (1997) Antifungal Drug Resistance: a Focus on Candida.
Clinical Updates in Fungal Infections 1: 1-6.
147. McCord 1M (1996) Effects of positive iron status at a cellular level. Nut. Rev 54(3): 85-
88.
148. Mekalanos JJ (1992) Environmental signals controlling expressIOn of virulence
determinants in bacteria. J Bacteriol17 4: 1-7.
149. Mishra P & Prasad R (1987) Alterations in fatty acyl composition can selectivity affect
amino acid transport in Saccharomyces cerevisiae. Biochem Int 15: 499-508.
200
CR,gferences
ISO. Mishra P & Prasad R (1989) Relationship between ethanol tolerance and fatty acyl
composition of Saccharomyces cerevisiae. Appl Microbiol Biotechnol30: 294-298.
151. Moelling C, Oberschlacke R, Ward P, Karijolich J, Borisova K, Bjelos N and Bergeron L
(2007) Metal-dependent repression of siderophore and biofilm formation in Actinomyces
naeslundii. FEMS Microbiol Lett 275: 214-220.
152.Monge AR, Roma'n E, Arana DM, PIa J and Nombela C (2009) Fungi sensmg
environmental stress. Clinical Microbiology and Infection. 15 (1): 17-19
153. Morgan EH (1979) Studies on the mechanism of iron release from transferrin. Biochim
Biophys Acta 580: 312-326.
154.Morschhauser J, Barker KS, Liu TT, Bla BWJ, Homayouni R and Rogers PD (2007) The
transcription factor Mrr I p controls expression of the MDR I efflux pump and mediates
multidrugresistance in Candida albicans. PLoS Pathog 3: e164.
ISS. Mukherjee PK, Zhou G, Munyon Rand Ghannoum MA (2005) Candida biofilm: a well
designed protected environment. Med MycoI43:191-208.
156.Mukhopadhyay CK, Mazumder B and Fox PL (2000) Role of hypoxia-inducible factor-I
in transcriptional activation of ceruloplasmin by iron deficiency. J.BioI.Chem. 275:
21048-21054.
157. Mukhopadhyay CK, Kohli AK and Prasad R (2002) Drug susceptibilities of yeast cells
are affected by membrane lipid composition. Antimicrob Agents Chemother 46: 3695-
3705.
158.Mukhopadhyay CK, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A and Prasad R
(2004) Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of
Multidrug Resistance in Candida albicans. Antimicrob Agents Chemother 48: 1778-
1787.
201
CR,gferences
159. Murphy DJ and Vance J (1999) Mechanisms of lipid-body formation. Trends Biochem
Sci. 24(3): 109-15.
160. Nyi1assi I, Papp T, Tako M, Nagy E and Vagvolgyi C (2005) Iron gathering of
opportunistic pathogenic fungi. A mini review. Acta Microbiol Immunol Hung 52: 185-
197.
161. Odds FC (1988) Candida and Candidosis: A Review and Bibliography (London).
162.Pao SS, Paulsen IT and Saier MHJr (1998) Major Facilitator Superfamily. Microbiol Mol
Bioi Rev 62: 1-34.
163.Park SH, Koh SS, Chun JH, Hwang HJ and Kang HS (1999) Nrg1 is a transcriptional
repressor for glucose repression of STAI gene expression in Saccharomyces cerevisiae.
Mol Cell BioI. 19: 2044-50.
164. Patrauchan MA, Sarkisova SA and Franklin MJ (2007) Strain-specific proteome response
of Pseudomon,as aeruginosa to biofilm-assosiated growth and to calcium. Microbiology
153: 3838-3851.
165. Pendrak ML and Roberts DD (2007) Hemoglobin is an effective inducer of hyphal
differentiation in Candida albicans. Med Mycol45: 65-71.
166.Pendrak ML, Chao MP, Van SS and Roberts DD (2004a) Heme oxygenase in Candida
albicans is regulated by hemoglobin and is necessary for metabolism of exogenous heme
and hemoglobin to alpha-biliverdin. J Bioi Chern 279: 3426-3433.
167. Pendrak ML, Van SS and Roberts DD (2004b) Sensing the host environment: recognition
of hemoglobin by the pathogenic yeast Candida albicans. Arch Biochem Biophys 426:
148-156.
202
~ferences
168.Perepnikhatka V, Fischer Fl, Niimi M, Baker RA, Cannon RD, Wang YK, Sherman F
and Rustchenko E (1999) Specific Chromosome Alterations in Fluconazole-Resistant
Mutants of Candida albicans. J Bacteriol181: 4041-4049.
169. Perrone GG, Tan SX and Dawes IW (2008) Reactive oxygen species and yeast apoptosis.
Biochim. Biophys. Acta. 1783: 1354-1368.
170. Pfaller MA and Diekema Dl (2007) Epidemiology of invasive candidiasis: a persistent
873 public health problem. Clin. Microbiol. Rev. 20: 133-163.
171.Posey lE and Gherardini FC (2000) Lack of role of iron in Lyme disease pathogen.
Science 288 (54710): 1651- 1653.
172.Prasad R (1991) Candida albicans: Cellular and Molecular Biology. Springer-Verlag,
Berlin.
173. Prasad R, De WP, Goffeau A and Balzi E (1995) Molecular cloning and characterization
of novel gene of Candida albicans, CDRI Conferring multiple resistance to drugs and
antifungals. Curro Genet. 27:320-329.
174. Prasad R, Gupta N and Gaur M (2004) Molecular basis of antifungal resistance III
pathogenic fungi. p. 357-414. In G. San-BIas and R. A. Calderone (ed.), Pathogenic fungi
-Host interactions and emerging strategies for control, Caister Academic Press, England.
175. Prasad R, Panwar SL and Krishnamurthy S (2000) Drug Resistance Mechanisms Of
Human Pathogenic Fungi -IN The Book by Marcel Dekker- "Fungal Pathogenesis:
Principles and Clinical Applications ".
176. Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK and
Prasad R (2010) Morphogenic Regulator EFG 1 Affects Drug Susceptibilities of
Pathogenic Candida albicans FEMS Yeast Res. : epub.
203
<R.§ferences
177. Prasad T, Chandra A, Mukhopadhyay CK and Prasad R (2006) Unexpected link between
iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and
drug diffusion, leading to drug-susceptible cells. Antimicrob Agents Chemother 50: 3597-
3606.
178. Prasad T, Saini P, Gaur NA, Vishwakarma RA, Khan LA, Haq QM and Prasad R (2005)
Functional analysis of CaIPTl, a sphingolipid biosynthetic gene involved in multidrug
resistance and morphogenesis of Candida albicans. Antimicrob Agents Chemother 49:
3442-3452.
179. Radisky D and Kaplan J (1999) Regulation of transition metal across the yeast plasma
membrane. J Bioi Chem 274: 4481-4484.
180. Ramage G, Matrinez JP and Lopez-Ribot JL (2006) Candida biofilms on implanted
biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986.
181. Ramage G, Vande WK, Wickes BL and Lopez-Ribot JL (2001) Standardized method for
in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrobial
Agents and Chemotherapy 45: 2475- 2479.
182.Ramage G, VandeWalle K, Lopez-Ribot JL and Wickes BL (2002) The filamentation
pathway controlled by the Efgl regulator protein is required for normal biofilm formation
and development in Candida albicans. FEMS Microbiol Lett 214: 95-100.
183.Ramage G, Wickes BL and Lopez-Ribot JL (2007) Inhibition on Candida albicans
biofilm formation using divalent cation chelators (EDTA). Mycopathol164: 301-306.
184. Ramanan N and Wang Y (2000) A high-affinity iron permease essential for Candida
albicans virulence. Science 288: 1062-1064.
204
~ferences
185. Rex JH, Pfaller MA, Galgiani IN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA,
Lancaster M, Odds FC, Rinaldi MG, Walsh TJ and Barry AL (1997) Development of
Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework
and Analysis of In Vitro-In Vivo Corrrelation Data for Fluconazole, ltraconazole and
Candida Infections. Clin Infect Dis 24: 235-247.
186. Reynolds TB and Fink RG (2001) Baker's yeast, a model for fungal biofilm formation.
Science 291: 878-881
187.Robbins N, Collins C, Morhayim J, Leah E. Cowen LE (2010) Metabolic control of
antifungal drug resistance. Fungal Genet. Bioi 47 (2): 81-93
188.Roepe PD (2001) pH and multi drug resistance. Novartis Found Symp. 240: 232-47
189.Romani L, Bistoni F, Puccetti P (2003) Adaptation of Candida albicans to the host
environment: the role of morphogenesis in virulence and survival in mammalian hosts.
Curro Opin. Microbiol. 6: 338-343.
190.Rosa JL, Victor L. Boyartchuk, Zhu LJ and Kaufman PD (2010) Histone
acetyltransferase Rttl09 is required for Candida albicans pathogenesis Proc. Nat!. Acad.
Sci 107 (4): 1594-1599.
191.Rouault TA and Tong WH (2008) Iron-sulfur cluster biogenesis and human disease.
Trends Genet 24: 398-407.
192. Ruprich-Robert G, Chapeland-Leclerc F, Boisnard S, Florent M, Bories G and Papon N
(2008) Contributions of the response regulators Ssk1p and Skn7p in the pseudohyphal
development, stress adaptation, and drug sensitivity of the opportunistic yeast Candida
lusitaniae. Eukaryot Cell 7:1071-4.
205
1?§ferences
193.Russell NJ, Evans RI, Steeg PF, Hellemons J, Verheul A and Abee T. (1995)
Membranes as a target for stress adaptation. Int J Food Microbiol. 28(2):255-61.
194. Sabie FT and Gadd GM (1992) Effect of nucleosides and nucleotides and the relationship
between cellular adenosine 3', 5'-cyclic monophosphate (cyclic AMP) and germ tube
formation in Candida albicans. Mycopathologia. 119: 147-56.
195. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning, a laboratory manual.
Cold Spring Harbor Laboratory Press, New York.
196. Sanglard D, Ischer F, Monod M and Bille J (1997) Cloning of Candida albicans genes
conferring resistance to azole antifungal agents: characterization of CDR 2 , a new
multi drug ABC transporter gene. Microbiology 143: 405-416.
197. Sanglard D, Ischer F, Monod M and Bille J (1996) Susceptibilities of Candida albicans
Multidrug Transporter Mutants to Various Antifungal Agents and Other Metabolic
Inhibitors. Antimicrob Agents Chemother 40: 2300-2305.
198. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M and Bille J. (1995) Mechanisms
of Resistance to Azole Antifungal Agents in Candida albicans Isolates From AIDS
Patients Involve Specific Multidrug Transporters. Antimicrob Agents Chemother 39:
2378-2386.
199. Santos R, Buisson N, Knight S, Dancis A, Camadro JM and Lesuisse E (2003) Haemin
uptake and use as an iron source by Candida albicans: role of CaHMXl-encoded haem
oxygenase. Microbiology 149: 579-588.
200. Schaible UE and Kaufmann SHE (2004) Iron and microbial infection. Nat Rev Microbiol
2: 46-54.
201. Schrettl M, Kim HS, Eisendle M Kragl c, Nierman WC, Heinekamp T, Werner ER
Jacobsen I, Illmer P, Yi H, Brakhage AA and Haas H (2008) SreA-mediated irOl
regulation in Aspergillus fumigatus. Mol Microbiol70: 27-43.
206
CRgferences
202. Setiadi ER, Doedt T, Cottier F, Noffz C and Ernst JF (2006) Transcriptional response of
Candida albicans to hypoxia: linkage of oxygen sensing and Efg 1 p-regulatory networks.
J Mol Bioi 361: 399-411
203.Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS and Fonzi WA (1999)
HWP 1 functions in the morphological development of Candida albicans downstream of
EFGl, TUPl, and RBFl. J Bacteriol181: 5273-9.
204. Shea JM and Poeta MD (2006) Lipid signaling III pathogenic fungi Curr Opin
Microbiol, 9:352-358
205. Silver PM, Oliver BG and White TC (2004) Role of Candida albicans transcription
factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 3: 1391-1397.
206. Singh A, Prasad T, Kapoor K, MandaI A, Roth M, Welti R and Prasad R (2010)
Phospholipidome of Candida: Each species of Candida has distinctive phospholipid
molecular species. Omics (in press).
207. Skovsgaard T, Nielsen D, Maare C and Wasserman K (1994) Cellular Resistance to
Cancer Chemotherapy. Int Rev Cyto1156: 77-157.
208. Smith RL and Johnson AD (2000) Turning genes off by Ssn6-Tup 1: a conserved system
of transcriptional repression in eukaryotes. Trends Biochem Sci. 25: 325-30.
209. Sonneborn A, Bockmuhl DP and Ernst JF (1999a) Chlamydospore formation in Candida
albicans requires the Efg1 p morphogenetic regulator. Infect Immun 67: 5514-5517.
210. Sonneborn A, Bockmuhl DP, Gerads M, Kurpanek K, Sanglard D and Ernst JF (2000)
Protein Kinase A Encoded by TPK2 Regulates Dimorphism of Candida albicans. Mol
Microbiol35: 386-396.
207
~ferences
211. Sonneborn A, Tebarth B and Ernst JF (1999b) Control of white-opaque phenotypic
switching in Candida albicans by the Efglp morphogenetic regulator. Infect Immun 67:
4655-4660.
212.Sosinska GJ, de Groot PWJ, Joost M, de Mattos T, Dekker HL, de Koster CG,
Hellingwerf KJ and Klis FM (2008) Hypoxic conditions and iron restriction affect the
cell-wall proteome of Candida albicans grown under vagina-simulative conditions
Microbiology 154: 510-520.
213. Spacek J, Jilek P, Buchta V, Forstl M, Hronek M and Holeckova M. (2005) The serum
levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal
candidosis during attack, remission and in healthy controls. Mycoses. 48: 391-395.
214. Stanhill A, Schick N and Engelberg D (1999) The yeast ras/cyclic AMP pathway induces
invasive growth by suppressing the cellular stress response. Mol Cell Bio!. 19: 7529-38.
215. Stathopoulos-Gerontides A, Guo JJ, and Cyert MS (1999) Yeast ca1cineurin regulates
nuclear localization of the Crzl p transcription factor through dephosphorylation. Genes
Dev.13:798-803.
216. Stearman R (1996) A permease-oxidase complex involved in high-affinity iron uptake in
yeast. Science 271: 1552-1557.
217. Steinbach WJ, Reedy JL, Cramer RAPerfect JR, and Heitman J (2007) Harnessing
calcineurin as a novel anti-infective agent against invasive fungal infections. Nat. Rev.
Microbio!. 5:418-430.
218. Stoldt VR, Sonneborn A, Leuker CE and Ernst JF (1997) Efg 1 p, an essential regulator of
morphogenesis of the human pathogen Candida albicans, is a member of a conserved
class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16: 1982-
1991.
208
CR.fferences
219. Sugimoto Y, Sakoh H and Yamada K (2004) IPC Synthase as a Useful Target for
Antifungal Drugs. Curr Drug Tar - Infect Dis 4(4): 311-322.
220. Sukhai M and Miller MP (2000) Regulation of the multidrug resistance genes by stress
signals. J. Pharm. Pharm. Sci. 3: 268-280.
221. Sun S and Chasteen ND (1992) F erroxidase kinetics of horse spleen apoferritin. J Bioi
Chem267:25l60-25l66.
222. Sweet SP and Douglas LJ (1991) Effect of iron deprivation on surface composition and
virulence determinants of Candida albicans. J Gen Microbiol137: 859-865.
223. Talibi D and Raymond M (1999) Isolation of a putative Candida albicans transcriptional
regulator involved in pleiotropic drug resistance by functional complementation of a pdr 1
pdr3 mutation in Saccharomyces cerevisiae. J Bacteriol181: 231-240.
224. Thakur JK, Arthanari H, Yang F, Pan SJ, Fan X, Breger J, Frueh DP, Gulshan K, Li DK,
Mylonakis E, Struhl K, Rowley WSM, Cormack BP, Wagner G and Naar AM (2008) A
nuclear receptor like pathway regulating multidrug resistance in fungi. Nature 452: 604-
609.
225. Torelli R, Posteraro B, Ferrari S La Sorda M, Fadda G, Sanglard D and Sanguinettu M
(2008) The A TP-binding cassette transporter-encoding gene CgSNQ2 is contributor to
the CgPdrl-dependent azole resistance in Candida glabrata. Mol Microbiol 68: 186-20 l.
226. Torti FM@)Torti SV (2002) Regulation of ferritin genes and protein. Blood 99: 3505-
3516.
227. Tsai HF, Krol AA, Sarti KE and Bennett JE (2006) Candida glabrata PDR1, a
transcriptional regulator of a pleiotropic drug resistance network, mediates azole
resistance in clinical isolates and petite mutants. Antimicrob Agents 50: 1384-1392.
209
CRgferences
228. Vanden Bossche Hand Koymans L (1998) Cytochromes P450 in Fungi. Mycoses 41: 32-
38.
229. Vanden Bossche H, Willemsens G and Marichal P (1987) Anti-Candida drugs- the
biochemical basis for their activity. Crit Rev MicrobiollS (1) : 57-72.
230. Vazquez N, Walsh TJ, Friedman D, Chanock SJ, and Lyman CA (1998) Interleukin-15
augments superoxide production and microbicidal activity of human monocytes against
Candida albicans.Infect.Immun. 66:145-150.
231. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD and Rogers PD (2006)
Pdrl regulates multi drug resistance in Candida glabrata: gene disruption and genome
wide expression studies. Mol Microbiol 61: 704-722.
232. Vinolo MA, Hatanaka E, Lambertucci RH, Newsholme P and Curi R (2009) Effects of
short chain fatty acids on effector mechanisms of neutrophils.Cell Biochem Funct 27:48-
55.
233. Vorl and LH, Ulvatne H, Andersen J, Haukland HH, Rekdal 0, Svendsen JS and
Gutteberg TJ (1999) Antibacterial effects of lactoferricin B. Scand J Infect Dis 31: 179-
184.
234. Weinberg ED (1984) Iron withholding: a defense against infection and neoplasia. Physiol
Rev 64: 65-102.
235. Weinberg ED (1999a) The role of iron in protozoa and fungal infectious diseases. J
Eukaryot Microbiol46: 231-238.
236. Weinberg ED (1999b) Iron loading and disease surveillance. Emerg Infect Dis S: 346-
352.
210
1?§ferences
237. Weissman Z, Shemer R and Kornitzer D (2002) Deletion of the copper transporter
CaCCC2 reveals two distinct pathways for iron acquisition in Candida albicans. Mol
Microbiol44: 1551-1560.
238. Weissman Z, Shemer R, Conibear E and Kornitzer D (2008) An endocytic mechanism
for haemoglobin-iron acquisition in Candida albicans. Mol Microbiol. 61 (1): 201-217.
239. Welch KD, Van Eden ME and Aust SD (2001) Modification of ferritin during iron
loading. Free Radical Bioi Med 31: 999-1006.
240. Welti R, Li W, Li M, Sang Y, Biesiada H, Zhou HE, Rajashekar CB, Williams TD and ----Wang X (2002). Profiling membrane lipids in plant stress -responses. Role of
phospholipase D alpha in freezing-induced lipid changes in Arabidopsis. 1. Bioi. Chem.
277:31994-32002.
241. White TC (1997) Increased mRNA Levels of ERG 16, CDRs, and MDR1 Correlate With
Increased Azole Resistance in Candida albicans Isolates From a Patient Infected With
Human Immunodeficiency Virus. Antimicrob Agents Chemother 41: 1482-1487.
242. White TC, Holleman S, Dy F, Mirels LF and Stevens DA (2002) Resistance mechanisms
in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46: 1704-1713.
243. White TC, Marr KA and Bowden RA (1998) Clinical, Cellular, and Molecular Factors
That Contribute to Antifungal Drug Resistance. Clin Microbiol Rev 11: 382-402.
244. Whiteway M (2000) Transcriptional Control of Cell Type and Morphogenesis in Candida
albicans. Curr Op in Microbiol3: 582-588. --245. Whiteway M, Dignard D and Thomas DY (1992) Dominant negative selection of
heterologous genes: isolation of Candida albicans genes that interfere with
Saccharomyces cerevisiae mating factor-induced cell cycle arrest. Proc Natl Acad Sci 89:
9410-4.
211
1?§ferences
246. Wu :XZ, Cheng AX, Sun LM, Sun SJ, Lou HX (2009) Plagiochin E, an antifungal
bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced
reactive oxygen species accumulation in Candida albicans Biochimica et Biophysica Acta
1790: 770-777.
247.Xu Y, Wang Y, Van L, Liang RM, Dai BD, Tang RJ, Gao PH and Yuan-Ying Jiang YY
(2009) Proteomic Analysis Reveals a Synergistic Mechanism of Fluconazole and
Berberine against Fluconazole-Resistant Candida albicans: Endogenous ROS
Augmentation Proteome Res. 8 (11): 5296-5304.
248. Yaacov RB, Knoller S, Caldwell GA, Becker JM and Koltin Y (1994) Candida albicans
gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.
Antimicrob Agents Chemother 38:648-652.
249. Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Sandra L. Zas R, KE,
Ghannoum MA and Hoyer LL (2007) Temporal analysis of Candida albicans gene
expression during biofilm development. Microbiology 153: 2373-2385.
250.Zhang Q, Chieu HK, Low CP, Zhang S, Heng CK, and Yang H (2003)
Schizosaccharomyces pombe Cells Deficient in Triacylglycerols Synthesis Undergo
Apoptosis upon Entry into the Stationary Phase. J Bio!. Chem. 278(47): 47145-47155.
251. Zhang X, Essman M, Burt ET and Larsen B (2000) Estrogen effects on Candida albicans:
a potential virulence-regulating mechanism. J Infect. Dis. 181: 1441-1446.
252.Zweytick D, Leitner E, Kohlwein SD, Yu C, Rothblatt J and Daum G. (2000)
Contribution of Are 1 p and Are2p to steryl ester synthesis in the yeast Saccharomyces
cerevisiae. Eur. J Biochem. 267, 1075-1082.
212
Top Related